#52026M12382EU review of CVC’s planned acquisition of DSM’s Animal Nutrition and Health business
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
The European Commission is reviewing CVC’s planned purchase of DSM-Firmenich’s Animal Nutrition and Health business, which makes animal nutrition ingredients such as vitamins, carotenoids, premixes, performance products, precision services and aroma ingredients. The case may be handled under the EU’s simplified merger review process, which is usually used for transactions that appear unlikely to raise major competition concerns. Competitors, customers and other interested parties have 10 days from publication to send comments to the Commission, using case reference M.12382.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- CVC plans to acquire sole control of DSM-Firmenich’s Animal Nutrition and Health business.
- The European Commission is assessing whether the transaction falls under EU merger control rules.
- Interested third parties have 10 days from publication to submit comments to the Commission.
Obligations
What this law requires
Interested third parties wishing to comment on the proposed concentration must submit their observations to the European Commission within 10 days of publication.
Any observations submitted to the Commission must specify the case reference: M.12382 – CVC / DSM ANIMAL NUTRITION AND HEALTH BUSINESS.